2 weeks, 5 days ago (2008-10-30 01:42:00)
by DewDiligence
Here’s the CLDA-AVRX deal for archival purposes. The $12.49 share price of CLDA cited in the PR is an artificial figure inasmuch as CLDA’s closing price on Monday was $10.81; this lowers the nominal deal value (excluding the contingent rights) from $10M to $8.7M, which is barely more than AVRX’s net cash. http://biz.yahoo.com/bw/081028/20081028005894.html › Clinical Data, ...
Source:
Investors Hub - Discussion Groups
Forum: Biotech Values
Thread: Show this thread (1 post)
Size: 6,983 bytes
Links: advfn.com profile
Related Threads: Same Site | All Sites
Customize:
Forum: Biotech Values
Thread: Show this thread (1 post)
Related Threads: Same Site | All Sites
Customize:

